COVID-19 RESPONSE - We are committed to supporting our scientific community during this pandemic. Learn more 

3D Cell Imaging


Optimizing high-content screening tools for physiologically-relevant 3D 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 models

Overcome challenges in high-throughput 3D imaging

Optimizing high-content screening tools for physiologically-relevant 3D in vitro models

Elodie Vandenhaute, Study Director | HCS Pharma
Zied Souguir, Senior Scientist | HCS Pharma
Dan O’Connor, North America Bioimaging Director | Molecular Devices

Watch our webinar with HCS Pharma, a biotechnology start-up company based in France, as we discuss the biological characterization of cells in 3D matrices for liver, brain and adipose tissues, and cancer modeling, using BIOMIMESYS® hydroscaffold technology. We also discuss high-content screening solutions for examining 3D in vitro models.

Key learning objectives:

  • Describe the differentiating factors between different 3D cell culture systems
  • Utilizing a relevant 3D cell culture platform for liver, brain, adipose tissue, and disease modeling (human cells)
  • Optimizing setup of a high-content screening platform for 3D in vitro models

Register to view webinar on demand